Linq Therapeutics Private Limited - Company Profile

It is a healthcare private limited company based in Pune City, Maharashtra, India, established in 2015.
2015 Pune City, Maharashtra, India Active
Last Updated:
Access Report
About Linq Therapeutics Private Limited

Linq Therapeutics Private Limited, a active private limited company, was established on 29 September 2015 in Pune City, Maharashtra, India. Engaging in diagnostic centers & pathology labs within the healthcare sector, it holds CIN: U74999PN2015PTC156595. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.

It upholds a compliant status. Employing 5 professional, Its leadership includes Pathik Pradeep Divate (Director), Uma Pradeep Divate (Director), Cowasji Jehangir Jehangir (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Office No. 309-311, Millenium Star,, P 17 Fp 153 Cts 36 To 40, Sangamwadi, Pune City, Maharashtra, 411001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999PN2015PTC156595

  • Registration Number

    156595

  • Incorporation Date

    29 September 2015

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹5.00 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 5.00 M
  • Company Age 10 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 17.28%
  • Profit Growth **** -19.03%
  • Ebitda **** 31.69%
  • Net Worth 99.18%
  • Total Assets -17.36%
Company report

Linq Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Linq Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Linq Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Pathik Pradeep Divate Director 29 Sep 2015 Current
Uma Pradeep Divate Director 29 Sep 2015 Current
Cowasji Jehangir Jehangir Director 25 Nov 2020 Current
Jehangir Hirji Cawasji Jehangir Director 29 Sep 2015 Current
Geeta Pathik Divate Director 25 Nov 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Linq Therapeutics.

Linq Therapeutics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.28% increase. The company also saw a substantial fall in profitability, with a 19.03% decrease in profit. The company's net worth Soared by an impressive increase of 99.18%.

Linq Therapeutics revenue growth over time
Linq Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 17.28%
*******
*******
*******
*******
Revenue from Operations
*******
 31.48%
*******
*******
*******
*******
Total Assets
*******
 -17.36%
*******
*******
*******
*******
Profit or Loss
*******
 -19.03%
*******
*******
*******
*******
Net Worth
*******
 99.18%
*******
*******
*******
*******
EBITDA
*******
 31.69%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Linq Therapeutics?

In 2019, Linq Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Linq Therapeutics?

Linq Therapeutics has a workforce of 5 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Linq Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Linq Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Linq Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    Linq Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Linq Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was recorded as a recent event.

  • Director Appointment

    Cowasji Jehangir Jehangir was appointed as a Director was appointed as a Director on 25 Nov 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.

  • Director Appointment

    Progress on Geeta Pathik Divate was appointed as a Director was appointed as a Director on 25 Nov 2020 & has been associated with this company since 5 years 3 months . was documented.

  • Director Appointment

    Pathik Pradeep Divate was appointed as a Director was appointed as a Director on 29 Sep 2015 & has been associated with this company since 10 years 5 months . was recorded as a recent event.

  • Director Appointment

    Uma Pradeep Divate was appointed as a Director was appointed as a Director on 29 Sep 2015 & has been associated with this company since 10 years 5 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Linq Therapeutics Private Limited?

The CIN of Linq Therapeutics Private Limited is U74999PN2015PTC156595.

Where is Linq Therapeutics Private Limited headquartered?

Linq Therapeutics Private Limited is headquartered at Office No. 309-311, Millenium Star,, P 17 Fp 153 Cts 36 To 40, Sangamwadi, Pune City, Maharashtra, 411001.

When was Linq Therapeutics Private Limited incorporated?

Linq Therapeutics Private Limited was incorporated on 29 September 2015.

Who are the current directors of Linq Therapeutics Private Limited?

The current directors of Linq Therapeutics Private Limited are

What is the primary industry of Linq Therapeutics Private Limited?

The primary industry of Linq Therapeutics Private Limited is Healthcare.

Is Linq Therapeutics Private Limited a listed company?

Linq Therapeutics Private Limited is unlisted.

What is the capital structure of Linq Therapeutics Private Limited?

The authorized capital of Linq Therapeutics Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.

What is the compliance status of Linq Therapeutics Private Limited?

The compliance status of Linq Therapeutics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available